1
solid which was filtered (0.40 g, 32%). H NMR (300 MHz,
6
d -DMSO, 298 K, d in ppm, numbering following Fig. 1): 13.41
6.93 (m, 2 H, HO–C–CH and HO–C–CH–CH–CH), 4.91 (s, 2 H,
13
N–CH2). C NMR (300 MHz, d -DMSO, 298 K, d in ppm):
6
(s, 1H, OH), 8.74 (s, 1H, C7–H), 8.55 (d, J = 4.83 Hz, 1 H, C12–H),
1
167.75 (NLCH), 160.31 (HO–C), 149.83 (N–CH –C–CH–CH),
2
7
.80 (m, 1 H, C14–H), 7.50 (dd, J
1
= 7.60 Hz, J
2
= 1.59 Hz, 1 H,
147.59 (HO–C–C), 132.66 (N–CH
CH), 122.67 (HO–C–CH–CH), 118.84 (HO–C–CH–CH–CH),
118.69 (N–CH –C), 116.47 (HO–C–CH), 60.68 (N–CH ). MS:
m/z = 213 (M + H ), 196 (C H N ). Purity checked in HRMS
2
–C–CH), 131.86 (NLCH–C–
C3–H), 7.35 (m, 2 H, C15–H, C13–H, C6–H), 6.91 (m, 2 H, C4–H,
13
6
C5–H), 4.91 (s, 2 H, C9–H). C NMR (300 MHz, d -DMSO,
98 K, in ppm): 167.42 (C7), 160.52 (C2), 157.78 (C10), 149.26
C12), 136.99 (C14), 132.50 (C13), 131.79 (C3), 122.49 (C6), 122.09
C15), 118.72 (C1), 118.64 (C4), 116.47 (C5), 63.86 (C9).
O (212.25) calcd: C 73.57, N 13.20, H 5.70; found C
2
2
+
2
1
3
10
2
(
(TOF MS ES+): m/z = 213.1025 (calculated: 213.1028). FTIR
2
1
(
(KBr, cm ): 3049 (m, br, OH), 2868 (m), 2725 (m, br), 1630 (s),
1602 (s, CLN), 1580 (m), 1489 (m), 1458 (s), 1413 (m), 1389 (w),
1279 (m), 1250 (m), 1219 (w), 1151 (w, C–O), 1116 (w), 1065 (w),
13 12 2
C H N
21
72.97, N 11.44, H 5.45. FTIR (KBr, cm ): 3057 (m, br, OH), 2867
(
m) 1630 (s, CLN), 1589 (m), 1491 (m), 1474 (m), 1458 (m), 1435
1034 (m), 1009 (w), 800 (m), 754 (s).
3
5-Chloro-N-salicylidene 3-aminomethylpyridine (CH L Cl):
(m), 1389 (w), 1335 (w), 1279 (m), 1259 (w), 1220 (w), 1151 (w),
2
1
116 (w), 1099 (w), 1047 (m), 1007 (w), 893 (w), 839 (w), 802 (m),
54 (s). Yellow single crystals (plates) were obtained by recrystalli-
3-Aminomethylpyridine (2.40 mL, 1 equiv., 23.56 mmol) was
dissolved in benzene (70 mL) in a 250 mL round bottom flask
with a Dean–Stark setup. 5-Chloro-salicylaldehyde (3.69 g,
1 equiv., 23.56 mmol) was added to the mixture which
immediately turned to dark yellow. After refluxing for 24 h,
7
zation in hot hexane after slow evaporation.
3
2
N-Salicylidene 3-aminomethylpyridine (CH L ): 3-Amino-
methylpyridine (2.40 mL, 1 equiv., 23.56 mmol) was dissolved
in benzene (100 mL) in a 250 mL round-bottom flask with
a Dean–Stark setup. Salicylaldehyde (2.48 mL, 1 equiv.,
the solution was concentrated leading to a dark crude oil which
3
L Cl as a
was triturated in hexane in order to obtain pure CH
2
1
yellow microcrystalline powder (5.44 g, 93%). H NMR
2
3.56 mmol) was added to the solution giving rise to an
6
(300 MHz, d -DMSO, 298 K, d in ppm, numbering following
immediate coloration change to yellow. After refluxing the
mixture for 24 h, the dark yellow solution was evaporated to give
1
Fig. 2): 8.76 (s, 1 H, C8–H), 8.59 (d, J = 1.80 Hz, 1 H, C13–H),
a crude solid which was triturated in hexane affording pure
3
CH L as a strongly yellow microcrystalline powder (4.99 g,
8.51 (dd, J = 4.80 Hz, J = 1.60 Hz, 1 H, C11–H), 7.76 (dt, J =
1
2
1
7.83 Hz, J = 1.83 Hz, 1 H, C14–H), 7.61 (d, J = 2.67 Hz, 1 H,
2 1
2
1
6
9
9%). H NMR (300 MHz, d -DMSO, 298 K, d in ppm,
numbering following cif files available in ref. 20): 13.22 (s, 1 H,
OH), 8.76 (s, 1 H, C7–H), 8.60 (d, J = 1.90 Hz, 1 H, C11–H),
.51 (dd, J = 4.8 Hz, J = 1.6 Hz, 1 H, C10–H), 7.76 (d, J =
1
C6–H), 7.40 (m, 2 H, C15–H, C4–H), 6.92 (d, J = 8.85 Hz, 1 H,
1
3
6
C3–H), 4.85 (s, 2 H, C9–H). C NMR (300 MHz, d -DMSO,
298 K, d in ppm): 165.67 (C7), 159.12 (C5), 149.13 (C13), 148.59
(C11), 135.66 (C14), 134.04 (C2), 132.15 (C4), 130.56 (C6),
123.72 (C15), 121.01 (C1), 119.84 (C10), 118.48 (C3), 61.58 (C9).
1
8
1
2
1
7
.9 Hz, 1 H, C12–H), 7.49 (dd, J = 7.65 Hz, J = 1.68 Hz, 1 H,
1
2
C12–H), 7.42 (dd, 1 H, J
1
= 6.36 Hz, J
2
= 0.48 Hz, C5–H), 7.35
13 12 2
C H N O (212.25) calcd: C 63.29, N 11.36, H 4.43; found: C
(
m, 2H, C3–H and C13–H), 6.92 (m, 2H, C2–H and C4–H), 4.85
63.29, N 11.49, H 4.43. X-ray powder diffraction (u): 6.6 (s),
13.12 (w), 16.14 (m), 16.84 (w), 19.62 (m), 20.5 (m), 20.84 (w),
21.62 (s), 24.00 (s), 24.10 (m), 25.02 (m), 25.46 (m), 25.74 (m),
26.12 (s), 28.16 (m), 29.16 (m), 30.08 (m), 30.16 (m), 30.54 (w),
32.26 (m), 35.64 (w), 36.46 (w), 39.56 (w), 41.84 (w), 44.34 (w),
1
s, 2 H, C8–H). C NMR (300 MHz, d -DMSO, 298 K, d in
3
6
(
ppm): 168.36 (C7), 161.56 (C4), 150.34 (C11), 149.78 (C10),
36.84 (C12), 135.52 (C1), 133.79 (C3), 133.06 (C5), 124.97
C13), 120.01 (C9), 119.93 (C6), 117.68 (C2), 60.67 (C8).
O (212.25) calcd: C 73.57, N 13.20, H, 5.70; found: C
1
(
2
1
C
H
13 12
N
2
45.04 (w), 48.20 (w), 49.48 (w). FTIR (KBr, cm ): 3057 (w, br,
OH), 2995 (w), 2914 (w), 2850 (w), 1633 (s, CLN), 1576 (m), 1558
(w), 1448 (w), 1450 (m), 1416 (m), 1394 (w), 1369 (m), 1338 (m),
1308 (w), 1277 (s), 1232 (w), 1203 (w), 1184 (m), 1107 (m), 1092
(w), 1036 (m), 1022 (s), 955 (w), 910 (w), 891 (w), 833 (w), 820 (s),
802 (m), 777 (w), 716 (m), 710 (s). Yellow single crystals (long
needles) were obtained by recrystallization in hot hexane after
slow solvent evaporation.
7
1
2
3
1
3.12, N 12.87, H 5.59. X-ray powder diffraction (u): 9.66 (m),
5.18 (w), 17.92 (m), 19.34 (m), 19.70 (m), 20.50 (m), 21.18 (w),
2
1
1.62 (m), 23.86 (s), 27.42 (m), 32.98 (m). FTIR (KBr, cm ):
030 (w, br, OH), 2891 (w), 1630 (s, CLN), 1575 (m), 1491 (m),
458 (m), 1421 (m), 1400 (m), 1350 (w), 1317 (w), 1275 (m), 1213
(
(
w), 1198 (w), 1147 (w), 1113 (w), 1057 (m, C–O), 1028 (m), 993
m), 970 (w), 924 (w), 876 (m), 856 (m), 795 (m), 770 (s), 712 (m).
4
2
Yellow single crystals (plates) were obtained by recrystallization
in hot hexane after slow evaporation. An X-ray investigation has
5-Chloro-N-salicylidene 4-aminomethylpyridine (CH L Cl):
4-Aminomethylpyridine (2.38 mL, 1 equiv., 23.56 mmol) was
dissolved in benzene (70 mL) in a 250 mL round bottom flask
with a Dean–Stark setup. 5-Chloro-salicylaldehyde (3.69 g,
1 equiv., 23.56 mmol) was added to the mixture which
immediately turned to yellow. After refluxing for 24 h, the
revealed the same cell parameters as those in ref. 31.
4
L ): 4-Amino-
N-Salicylidene 4-aminomethylpyridine (CH
2
methylpyridine (2.38 mL, 1 equiv., 23.56 mmol) was dissolved
in benzene (100 mL) in a 250 mL round bottom flask with
a Dean–Stark setup. Salicylaldehyde (2.48 mL, 1 equiv.,
solution was concentrated giving crude orange oil which was
4
triturated in hexane affording pure CH L Cl as a yellow
2
3.56 mmol) was added in the mixture which immediately
2
1
microcrystalline powder (5.48 g, 94%). H NMR (300 MHz,
turned to yellow. After refluxing for 24 h, the solution was
6
d -DMSO, 298 K, d in ppm): 13.11 (s, 1 H, OH), 8.73 (s, 1 H,
concentrated leading to a yellow solid which was triturated in
4
L as a pale yellow powder
hexane in order to obtain pure CH
2
NLCH), 8.56 (m, 2 H, N–CH
2 1
–C–CH–CH), 7.63 (d, J = 3 Hz,
1
4.90 g, 98%). H NMR (300 MHz, d -DMSO, 298 K, d in ppm):
6
(
1 H, NLCH–C–CH), 7.36 (m, 3 H, N–CH –C–CH and HO–C–
2
1
J
3.20 (s, 1H, OH), 8.73 (s, 1 H, NLCH), 8.56 (dd, J = 4.41 Hz,
CH–CH), 6.95 (d, J = 8.85 Hz, 1 H, HO–C–CH), 4.85 (s, 2 H,
1
1
1
3
6
2
= 1.62 Hz, 2 H, N–CH
2
–C–CH–CH), 7.49 (m, 1 H, NLCH–
–C–CH–CH),
N–CH
2
). C NMR (300 MHz, d -DMSO, 298 K, d in ppm):
–C–CH–CH),
C–CH), 7.35 (m, 3 H, HO–C–CH–CH and N–CH
2
167.22 (NLCH), 160.05 (HO–C), 150.79 (N–CH
2
4
404 | CrystEngComm, 2012, 14, 4396–4406
This journal is ß The Royal Society of Chemistry 2012